Zafirlukast in Combination with Pseudohypericin Attenuates Spinal Cord Injury and Motor Function in Experimental Mice [Corrigendum]
Chen XG, Hua F, Wang SG, Xu YY, Yue HT, Sun J. Drug Des Devel Ther. 2018;12:2389–2402The authors have advised Figures 1 (on page 2393), Figure 3 (on page 2394), Figure 5 (on page 2395), Figure 7 and Figure 8 (on page 2396) are incorrect due to a fault in...
Saved in:
Main Authors: | Chen XG (Author), Hua F (Author), Wang SG (Author), Xu YY (Author), Yue HT (Author), Sun J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zafirlukast in combination with pseudohypericin attenuates spinal cord injury and motor function in experimental mice
by: Chen XG, et al.
Published: (2018) -
Experimental treatments to attenuate blood spinal cord barrier rupture in rats with traumatic spinal cord injury: A meta-analysis and systematic review
by: Li Deng, et al.
Published: (2022) -
[6]-Shogaol Attenuates Oxaliplatin-Induced Allodynia through Serotonergic Receptors and GABA in the Spinal Cord in Mice
by: Suyong Kim, et al.
Published: (2022) -
Recovery of Motor Function Following Spinal Cord Injury
Published: (2016) -
AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
by: Marcin Delijewski, et al.
Published: (2021)